| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0004 |